Evidence map›Paper›PMID 33260585›Full record

ReviewInternational journal of environmental research and public health2020

Treatment Processes for Microbial Resistance Mitigation: The Technological Contribution to Tackle the Problem of Antibiotic Resistance.

Gabriela Bairán, Georgette Rebollar-Pérez, Edith Chávez-Bravo, Eduardo Torres

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gabriela BairánInstituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
Georgette Rebollar-PérezFacultad de Ingeniería Química, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
Edith Chávez-BravoInstituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
Eduardo TorresInstituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.ORCID 0000-0003-3016-5028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances generated in medicine, science, and technology have contributed to a better quality of life in recent years; however, antimicrobial resistance has also benefited from these advances, creating various environmental and health problems. Several determinants may explain the problem of antimicrobial resistance, such as wastewater treatment plants that represent a powerful agent for the promotion of antibiotic-resistant bacteria (ARB) and antibiotic resistance genes (ARG), and are an important factor in mitigating the problem. This article focuses on reviewing current technologies for ARB and ARG removal treatments, which include disinfection, constructed wetlands, advanced oxidation processes (AOP), anaerobic, aerobic, or combined treatments, and nanomaterial-based treatments. Some of these technologies are highly intensive, such as AOP; however, other technologies require long treatment times or high doses of oxidizing agents. From this review, it can be concluded that treatment technologies must be significantly enhanced before the environmental and heath problems associated with antimicrobial resistance can be effectively solved. In either case, it is necessary to achieve total removal of bacteria and genes to avoid the possibility of regrowth given by the favorable environmental conditions at treatment plant facilities.

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialQuality of LifeWastewaterAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsGenes, BacterialTechnologyWaste Disposal, FluidAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Bacterial AgentsWastewateradvance oxidation processeselectrochemistrymicrobial resistanceozonationphotocatalysistreatment technologies

Identifiers

PMID33260585
PMCPMC7730199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.